SenoRx Mourns Death of CEO Lloyd Malchow
March 15 2010 - 4:41PM
SenoRx, Inc. (Nasdaq:SENO) today with great sadness announced the
death of its Chairman and Chief Executive Officer, Lloyd H.
Malchow. Mr. Malchow passed away Sunday evening, March 14. The
company extends its deepest condolences to his family.
It had been announced on February 8 that Mr. Malchow was taking
an indefinite medical leave of absence to undergo medical treatment
for cancer. Mr. Malchow is survived by his wife and two
daughters.
"Lloyd was an exceptional leader, business colleague and
friend," said John Buhler, SenoRx President, Chief Operating
Officer and Acting Chief Executive Officer. "He leaves a
legacy of excellence and accomplishment as a business leader.
His SenoRx family will miss him tremendously. He will
always be remembered for his passion and commitment to both his
work and his family. Through his compassion and tenacity he
inspired all of us to be our best."
About SenoRx
SenoRx (Nasdaq:SENO) develops, manufactures and sells minimally
invasive medical devices used by breast care specialists for the
diagnosis and treatment of breast cancer, including its EnCor®
vacuum-assisted breast biopsy system and Contura™ MLB catheter for
delivering radiation to the tissue surrounding the lumpectomy
cavity following surgery for breast cancer. SenoRx's field
sales organization serves over 2,000 breast diagnostic and
treatment centers in the United States. In addition, SenoRx
sells several of its products through distribution partners in more
than 30 countries outside the U.S. The company's line of breast
care products includes biopsy disposables, biopsy capital
equipment, diagnostic adjunct products and therapeutic disposables.
SenoRx is developing additional minimally invasive products for the
diagnosis and treatment of breast cancer. For more
information, visit the company's website at
www.senorx.com.
The SenoRx, Inc. logo is available at
http://www.globenewswire.com/newsroom/prs/?pkgid=3605
CONTACT: SenoRx, Inc.
Lila Churney, Director of Investor Relations
949.362.4800 ext.132
Senorx (MM) (NASDAQ:SENO)
Historical Stock Chart
From Jun 2024 to Jul 2024
Senorx (MM) (NASDAQ:SENO)
Historical Stock Chart
From Jul 2023 to Jul 2024